Current Treatment Options of Fontan Arrhythmias: Management

被引:1
|
作者
Marshall, Mayme [1 ]
Alnoor, Mohammad [1 ]
Balaji, Seshadri [1 ]
机构
[1] Oregon Hlth & Sci Univ, Div Cardiol, Dept Pediat, 707 SW Gaines St,CDRC-P, Portland, OR 97239 USA
关键词
Fontan; Arrhythmia; Atrial flutter; Supraventricular tachycardia; Ablation; Fontan conversion; RADIOFREQUENCY CATHETER ABLATION; TACHYCARDIA; OUTCOMES; PACEMAKERS; PATIENT; ADULTS; LEADS;
D O I
10.1007/s11936-020-00848-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose of the reviewArrhythmias are a common complication of patients with single ventricle anatomy who undergo the Fontan operation. This review will address current management strategies for acute and chronic arrhythmias.Recent findingsAlterations to surgical techniques, newer antiarrhythmic medications, and improvements in catheter ablation procedures have improved the management of patients with arrhythmias following Fontan palliation.SummaryArrhythmias predict poor prognosis for Fontan patients. Early and aggressive management of arrhythmias improve patient outcomes. For bradyarrhythmias, management strategies strive to maximize atrial pacing and minimize ventricular pacing. For tachyarrhythmias, urgent evaluation and aggressive interventions strive to convert and maintain sinus rhythm. Strategies include antiarrhythmic medications, catheter ablation, and early referral for Fontan conversion and arrhythmia surgery for those who do not respond. There is much interest in prophylactic arrhythmia surgery at the time of initial Fontan operation; however, the future role remains to be elucidated.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Management of patients with resistant hypertension: current treatment options
    Kumar, Nilay
    Calhoun, David A.
    Dudenbostel, Tanja
    INTEGRATED BLOOD PRESSURE CONTROL, 2013, 6 : 139 - 151
  • [22] Role of amiodarone in the management of atrial arrhythmias in adult Fontan patients
    Kawada, Satoshi
    Chakraborty, Praloy
    Roche, Lucy
    Oechslin, Erwin N.
    Silversides, Candice
    Wald, Rachel M.
    Downar, Eugene
    Harris, Louise
    Swan, Lorna
    Alonso-Gonzalez, Rafael
    Thorne, Sara
    Yamamura, Kenichiro
    Nanthakumar, Kumaraswamy
    Mondesert, Blandine
    Khairy, Paul
    Nair, Krishnakumar
    HEART, 2021, 107 (13) : 1062 - 1068
  • [23] FAILING FONTAN CIRCULATION "CURRENT OPTIONS FOR SURGICAL AND MEDICAL THERAPY"
    Harmandar, Bugra
    JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI, 2013, 76 (04): : 77 - 83
  • [24] CURRENT MANAGEMENT OF VENTRICULAR ARRHYTHMIAS
    ANDERSON, MH
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 1994, 52 (05) : 204 - 209
  • [25] Management of pheochromocytomas and paragangliomas: Review of current diagnosis and treatment options
    Eid, Michal
    Foukal, Jakub
    Sochorova, Dana
    Tucek, Stepan
    Stary, Karel
    Kala, Zdenek
    Mayer, Jiri
    Nemecek, Radim
    Trna, Jan
    Kunovsky, Lumir
    CANCER MEDICINE, 2023, 12 (13): : 13942 - 13957
  • [26] Keeping It "Current": A Review of Treatment Options for the Management of Supraventricular Tachycardia
    Tednes, Patrick
    Marquardt, Samantha
    Kuhrau, Shannon
    Heagler, Kristin
    Rech, Megan
    ANNALS OF PHARMACOTHERAPY, 2024, 58 (07) : 715 - 727
  • [27] A Review of the Current Management and Treatment Options for Superficial Venous Insufficiency
    Henry T. Zhan
    Ruth L. Bush
    World Journal of Surgery, 2014, 38 : 2580 - 2588
  • [28] Current developments and treatment options in the management of growing teratoma syndrome
    Skowron, Margaretha A.
    Hiester, Andreas
    Paffenholz, Pia
    Nestler, Tim
    Heidenreich, Axel
    Albers, Peter
    Nettersheim, Daniel
    ONKOLOGE, 2021, 27 (01): : 21 - 28
  • [29] Current and Future Treatment Options in the Management of Stage III NSCLC
    Li, Yuchen
    Juergens, Rosalyn Anne
    Finley, Christian
    Swaminath, Anand
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : 1478 - 1491
  • [30] Chronic urticaria - Aetiology, management and current and future treatment options
    Kozel, MMA
    Sabroe, RA
    DRUGS, 2004, 64 (22) : 2515 - 2536